TTP LabTech to Demonstrate New mosquito® LCP at ACA, Chicago
News Jul 07, 2010
TTP LabTech has today announced that it is showcasing its NEW mosquito® LCP liquid handler at the annual meeting of the American Crystallographic Association, Chicago, Illinois, July 24-29. For the first time since the product launch crystallographers will have the opportunity to see a live demonstration of the novel mosquito LCP instrument.
The mosquito LCP is a dedicated liquid handler that has been designed to facilitate the crystallisation of membrane proteins, such as G-protein coupled receptors, by offering a fully automated solution to lipid cubic phase (LCP) screening. It incorporates an auto-homing positive displacement syringe for the accurate and repeatable dispensing of LCP in addition to the standard disposable, positive displacement mosquito tips that guarantee zero cross contamination. This novel automation system enables LCP screening to be performed accurately and with ease and increases the throughput of crystallisation set-ups.
Joby Jenkins, mosquito Product Manager, TTP LabTech commented, “Following the late 2009 launch, mosquito LCP has generated great excitement and interest within the crystallography community.” He continued, “There are a number of technical difficulties that are regularly encountered when working with the LCP method such as liquid viscosity, the accurate dispensing of the LCP and the precise positioning of the drop. The mosquito LCP has been developed to overcome all these challenges and we are very pleased with the outcome”.
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018